A nurse-led intervention to improve management of virological failure in public sector HIV clinics in Durban, South Africa: A pre- and post-implementation evaluation.
暂无分享,去创建一个
M. Siedner | V. Marconi | H. Sunpath | R. Murphy | M. S. Moosa | T. Hatlen | S. Pillay | K. Naidoo
[1] D. Pillay,et al. Clinical outcomes after first‐line HIV treatment failure in South Africa: the next cascade of care , 2020, HIV medicine.
[2] R. Phillips,et al. Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa , 2020, EClinicalMedicine.
[3] S. Parisi,et al. Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis , 2019, PloS one.
[4] M. Fox,et al. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa , 2019, PLoS medicine.
[5] A. Phillips,et al. Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure , 2019, AIDS.
[6] M. Siedner,et al. Targeting the third '90': introducing the viral load champion. , 2018, Public health action.
[7] M. Gorgens,et al. Effectiveness of interventions for unstable patients on antiretroviral therapy in South Africa: results of a cluster‐randomised evaluation , 2018, Tropical medicine & international health : TM & IH.
[8] G. Maartens,et al. Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps , 2017, AIDS research and human retroviruses.
[9] R. Gray,et al. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda , 2017, BMC Infectious Diseases.
[10] Yunus Moosa,et al. Adult antiretroviral therapy guidelines 2017 , 2017, Southern African journal of HIV medicine.
[11] M. Siedner,et al. The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates , 2017, HIV clinical trials.
[12] T. Decroo,et al. Journey towards universal viral load monitoring in Maputo, Mozambique: many gaps, but encouraging signs , 2017, International health.
[13] Peter Charles Mgosha. Barriers to Switching Patients to Second-Line Antiretroviral Treatment Among Clinicians in Tanzania , 2017 .
[14] J. Mukherjee,et al. Community-Based ART Programs: Sustaining Adherence and Follow-up , 2016, Current HIV/AIDS Reports.
[15] John Ashmore,et al. Adherence clubs for long‐term provision of antiretroviral therapy: cost‐effectiveness and access analysis from Khayelitsha, South Africa , 2016, Tropical medicine & international health : TM & IH.
[16] J. Gallant,et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. , 2016, The New England journal of medicine.
[17] Robert Koch-Institut,et al. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study , 2016, The Lancet. Infectious diseases.
[18] N. Ford,et al. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression , 2016, Journal of the International AIDS Society.
[19] Jeffrey W. Eaton,et al. Sustainable HIV treatment in Africa through viral-load-informed differentiated care , 2015, Nature.
[20] P. Mayers,et al. Trends in task shifting in HIV treatment in Africa: Effectiveness, challenges and acceptability to the health professions , 2015, African journal of primary health care & family medicine.
[21] M. Egger,et al. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. , 2015, The lancet. HIV.
[22] A. Phillips,et al. Outcomes Following Virological Failure and Predictors of Switching to Second-line Antiretroviral Therapy in a South African Treatment Program , 2012, Journal of acquired immune deficiency syndromes.
[23] Matthias Egger,et al. Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. , 2008, Bulletin of the World Health Organization.
[24] B. Walker,et al. Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] R. Pieters,et al. Working Paper , 1994 .